Trang kết quả 12 cho Khu vực: Chăm sóc sức khỏe Ngành: Công nghệ sinh học Thị trường chứng khoán - Báo giá & giá
Danh sách tất cả các chứng khoán và vốn chủ sở hữu kèm giá, vốn hoá thị trường, PE và EPS
Tất cả các quốc gia
- {{country.name}}
- Tất cả các quốc gia
- Hoa Kỳ (1011)
- Úc (58)
- Áo (16)
- Bỉ (7)
- Brazil (16)
- Canada (83)
- Trung Quốc (94)
- Đan Mạch (6)
- Phần Lan (4)
- Pháp (41)
- Đức (737)
- Hồng Kông (46)
- Ấn Độ (19)
- Ai-len (1)
- Israel (19)
- Ý (4)
- Nhật Bản (37)
- Mexico (28)
- Hà Lan (3)
- New Zealand (1)
- Na Uy (14)
- Ba Lan (9)
- Nga (2)
- Hàn Quốc (10)
- Tây Ban Nha (4)
- Thụy Điển (70)
- Thụy Sĩ (11)
- Đài Loan (67)
- Thái Lan (2)
- Thổ Nhĩ Kỳ (1)
- Vương quốc Anh (69)
Tất cả các sàn giao dịch
- {{item.name}}
- Tất cả các sàn giao dịch
- Amsterdam (3)
- ASX (58)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KSE (10)
- LSE (44)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- NasdaqCM (278)
- NasdaqGM (142)
- NasdaqGS (239)
- NSE (10)
- NYSE (10)
- NYSE American (20)
- NZSE (1)
- Oslo (14)
- Other OTC (322)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (47)
- Stockholm (70)
- Stuttgart (38)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (23)
Chăm sóc sức khỏe (2608)
- {{item.name}}
- Tất cả các khối
- Chăm sóc sức khỏe (2608)
Công nghệ sinh học (2608)
- {{item.name}}
- Tất cả các ngành
- Công nghệ sinh học (2608)
- Nhà sản xuất thuốc - Chung (279)
- Nhà sản xuất thuốc - Biệt dược & Thuốc gốc (1702)
- Gói y tế (57)
- Cơ sơ chăm sóc y tế (554)
- Nhà bán lẻ thuốc (155)
- Dịch vụ thông tin sức khỏe (420)
- Thiết bị y tế (913)
- Thiết bị & nguồn cung y tế (502)
- Chẩn đoán & nghiên cứu (427)
- Phân phối y tế (138)
| Tên Tên | Giá Giá |
% 24h Biểu đồ 7n 24h% & 7n |
Vốn hoá TT Vốn hóa thị trường | KH. LƯỢNG Khối lượng | Đáy 24h | Đỉnh 24h | Vốn hóa thị trường | Tỉ lệ P/E | EPS |
|---|
| Tên Tên | Giá Giá |
% 24h Biểu đồ 7n 24h% & 7n |
Vốn hoá TT Vốn hóa thị trường | KH. LƯỢNG Khối lượng | Đáy 24h | Đỉnh 24h | Vốn hóa thị trường | Tỉ lệ P/E | EPS | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Amarantus BioScience AMBS | $0.0001 — |
0
|
$63.04K — | $300.4K — | $0.0001 — | $0.0001 — | $63.04K — | 0 | -$0.01 — | |
| Adhera Therapeutics ATRX | $0.008099 — |
0
|
$58.49K — | $1 — | $0.008099 — | $0.008099 — | $58.49K — | 0 | -$1.17 — | |
| Statera Biopharma STAB | $0.0006999 — |
0
|
$49.99K — | $60.67K — | $0.0006999 — | $0.0006999 — | $49.99K — | 0 | -$2.36 — | |
| Neon Bloom NBCO | $0.02 — |
0
|
$43.89K — | $32.6K — | $0.02 — | $0.02 — | $43.89K — | 0 | -$1.41 — | |
| Propanc Biopharma PPCB | $0.0006999 — |
0
|
$36.5K — | $7.44M — | $0.0006999 — | $0.0008 — | $36.5K — | 0.0029 | $0.24 — | |
| Cell Source CLCS | $0.0008 — |
0
|
$30.84K — | $1K — | $0.0008 — | $0.0008 — | $30.84K — | 0 | -$0.18 — | |
| Itoco ITMC | $0.005 — |
0
|
$26K — | $30.11K — | $0.005 — | $0.005 — | $26K — | 0 | -$0.71 — | |
| Regenicin RGIN | $0.0001 — |
0
|
$15.35K — | $15K — | $0.0001 — | $0.0001 — | $15.35K — | 0 | -$0.01 — | |
| Rebus RBSH | $0.0001 — |
0
|
$3.21K — | $28 — | $0.0001 — | $0.0001 — | $3.21K — | 0.0050 | $0.02 — | |
| Omnimmune OMMH | $0.0001 — |
0
|
$980 — | $169.07K — | $0.0001 — | $0.0001 — | $980 — | 0 | -$0.2 — | |
| U.S. Stem Cell USRM | $0 — |
0
|
$641 — | $450 — | $0 — | $0 — | $641 — | 0 | $0 — | |
| Q BioMed QBIO | $0 — |
0
|
$145 — | $5K — | $0 — | $0 — | $145 — | 0 | -$0.02 — | |
| NLS Pharmaceutics NLSPW | $0.02999 — |
0
|
$0 — | $1.15K — | $0.02999 — | $0.04 — | $0 — | 0 | $0 — | |
| Callitas Health MPHMF | $0.0001 — |
0
|
$0 — | $19.57K — | $0.0001 — | $0.0001 — | $0 — | 0 | $0 — | |
| Novo Nordisk A/S N1VO34.SA | $85.68 17.37 USD |
-0.95
|
$3.01T 609.95B USD | $6.37K 1.29K USD | $85.05 17.24 USD | $86.39 17.51 USD | $3.01T 609.95B USD | 5.78 | $14.81 3 USD | |
| Novo Nordisk A/S NOVA.F | $122.5 133.91 USD |
-0.81
|
$545.72B 596.54B USD | $2.02K 2.2K USD | $120 131.18 USD | $123.5 135 USD | $545.72B 596.54B USD | 45.88 | $2.67 2.92 USD | |
| Novo Nordisk A/S NVON.MX | $2,267.99 134.29 USD |
+1.22
|
$5.23T 309.7B USD | $902 53.41 USD | $2,219.31 131.41 USD | $2,267.99 134.29 USD | $5.23T 309.7B USD | 36.52 | $62.09 3.68 USD | |
| Vertex Pharmaceuticals Incorporated VRTX34.SA | $563.36 114.18 USD |
+0.52
|
$582.26B 118.01B USD | $41 8.31 USD | $560.4 113.58 USD | $563.36 114.18 USD | $582.26B 118.01B USD | 28.48 | $19.78 4.01 USD | |
| Vertex Pharmaceuticals Incorporated VX1.DE | $402.1 439.55 USD |
+0.45
|
$104.87B 114.63B USD | $265 289.68 USD | $384.7 420.53 USD | $402.35 439.82 USD | $104.87B 114.63B USD | 28.21 | $14.25 15.58 USD | |
| Vertex Pharmaceuticals Incorporated VRTX.VI | $402.05 439.49 USD |
+0.35
|
$104.76B 114.52B USD | $26 28.42 USD | $401.2 438.57 USD | $402.65 440.15 USD | $104.76B 114.52B USD | 28.19 | $14.26 15.59 USD | |
| Vertex Pharmaceuticals Incorporated VX1.F | $403.05 440.59 USD |
+0.04
|
$104.44B 114.16B USD | $11 12.02 USD | $400.05 437.31 USD | $403.05 440.59 USD | $104.44B 114.16B USD | 28.26 | $14.26 15.59 USD | |
| Vertex Pharmaceuticals Incorporated VRTX.MX | $7,015.5 415.4 USD |
0
|
$1.9T 112.64B USD | $629 37.24 USD | $7,015.5 415.4 USD | $7,015.5 415.4 USD | $1.9T 112.64B USD | 27.02 | $259.57 15.37 USD | |
| Regeneron Pharmaceuticals, Inc. REGN34.SA | $83.2 16.86 USD |
-0.95
|
$550.05B 111.49B USD | $58 11.76 USD | $83.2 16.86 USD | $84 17.03 USD | $550.05B 111.49B USD | 28.68 | $2.9 0.59 USD | |
| Regeneron Pharmaceuticals, Inc. REGN.VI | $899.2 982.95 USD |
-1.21
|
$98.47B 107.64B USD | $12 13.12 USD | $896.8 980.32 USD | $902 986.01 USD | $98.47B 107.64B USD | 28.63 | $31.4 34.32 USD | |
| Regeneron Pharmaceuticals, Inc. REGN.MX | $16,289.76 964.55 USD |
0
|
$1.82T 107.54B USD | $213 12.61 USD | $16,289.76 964.55 USD | $16,289.76 964.55 USD | $1.82T 107.54B USD | 28.57 | $570.14 33.76 USD | |
| CSL CMXHF | $190 — |
+2.68
|
$93.03B — | $930 — | $185.1 — | $190 — | $93.03B — | 37.32 | $5.09 — | |
| CSL Limited CSJA.F | $87 95.1 USD |
+1.16
|
$84.76B 92.65B USD | $10 10.93 USD | $87 95.1 USD | $87 95.1 USD | $84.76B 92.65B USD | 36.86 | $2.36 2.58 USD | |
| CSL Limited CSJ.F | $174.62 190.88 USD |
+1.09
|
$84.69B 92.58B USD | $10 10.93 USD | $174.62 190.88 USD | $174.62 190.88 USD | $84.69B 92.58B USD | 37.15 | $4.7 5.14 USD | |
| Moderna, Inc. MRNA.VI | $120.46 131.68 USD |
+4.24
|
$47.68B 52.12B USD | $294 321.38 USD | $118.54 129.58 USD | $120.46 131.68 USD | $47.68B 52.12B USD | 0 | -$14.46 -15.8 USD | |
| Moderna, Inc. 0QF.F | $122 133.36 USD |
+4.11
|
$47.62B 52.05B USD | $185 202.23 USD | $118.22 129.23 USD | $122 133.36 USD | $47.62B 52.05B USD | 0 | -$14.41 -15.7 USD | |
| Moderna, Inc. 0QF.MU | $120.22 131.42 USD |
+1.73
|
$46.53B 50.86B USD | $100 109.31 USD | $118.18 129.19 USD | $120.4 131.61 USD | $46.53B 50.86B USD | 0 | -$14.42 -15.7 USD | |
| Moderna, Inc. MRNA.MX | $2,215 131.16 USD |
+3.02
|
$858.63B 50.84B USD | $1.15K 67.98 USD | $2,161 127.96 USD | $2,215 131.16 USD | $858.63B 50.84B USD | 0 | -$262.9 -15.5 USD | |
| Seagen Inc. S1GE34.SA | $56.7 11.49 USD |
0
|
$214.37B 43.45B USD | $0 0 USD | $0 0 USD | $0 0 USD | $214.37B 43.45B USD | 0 | $0 0 USD | |
| Seagen SGEN | $228.74 — |
0
|
$43.15B — | $0 — | $0 — | $0 — | $43.15B — | 0 | $0 — | |
| Seagen Inc. SGT.F | $208.6 228.03 USD |
0
|
$39.36B 43.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $39.36B 43.02B USD | 0 | $0 0 USD | |
| Samsung Biologics Co.,Ltd. 207940.KS | $784,000 591.79 USD |
+0.38
|
$55.8T 42.12B USD | $0 0 USD | $0 0 USD | $0 0 USD | $55.8T 42.12B USD | 0 | $0 0 USD | |
| Seagen Inc. SGEN.MX | $3,711.48 219.77 USD |
0
|
$700.22B 41.46B USD | $0 0 USD | $0 0 USD | $0 0 USD | $700.22B 41.46B USD | 0 | $0 0 USD | |
| Celltrion, Inc. 068270.KS | $193,000 145.68 USD |
+1.1
|
$39.92T 30.13B USD | $0 0 USD | $0 0 USD | $0 0 USD | $39.92T 30.13B USD | 0 | $0 0 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.DE | $227.2 248.36 USD |
0
|
$27.27B 29.81B USD | $6 6.56 USD | $227.2 248.36 USD | $227.2 248.36 USD | $27.27B 29.81B USD | 0 | -$7.12 -7.7 USD | |
| UCB SA UNC0.F | $60.5 66.13 USD |
+2.54
|
$23.85B 26.07B USD | $4 4.37 USD | $60.5 66.13 USD | $60.5 66.13 USD | $23.85B 26.07B USD | 68.75 | $0.88 0.96 USD | |
| UCB SA UNC.F | $122.65 134.07 USD |
+1.83
|
$23.68B 25.89B USD | $40 43.73 USD | $122.65 134.07 USD | $122.65 134.07 USD | $23.68B 25.89B USD | 69.68 | $1.76 1.92 USD | |
| BioNTech SE 0A3M.IL | $93.18 — |
+1.22
|
$25.63B — | $522 — | $91.8 — | $93.23 — | $25.63B — | 5.17 | $18 — | |
| UCB SA UCB.VI | $121.6 132.93 USD |
-0.73
|
$23.09B 25.24B USD | $0 0 USD | $121.6 132.93 USD | $121.6 132.93 USD | $23.09B 25.24B USD | 69.09 | $1.76 1.92 USD | |
| UCB SA UCBJF | $132 — |
0
|
$25.05B — | $623 — | $132 — | $132 — | $25.05B — | 69.47 | $1.9 — | |
| Genmab A/S GE9.DE | $331 361.83 USD |
0
|
$21.66B 23.68B USD | $77 84.17 USD | $331 361.83 USD | $331 361.83 USD | $21.66B 23.68B USD | 68.12 | $4.86 5.31 USD | |
| argenx SE 1AEA.F | $342 373.85 USD |
+5.56
|
$21.64B 23.66B USD | $10 10.93 USD | $342 373.85 USD | $342 373.85 USD | $21.64B 23.66B USD | 0 | -$5.25 -5.7 USD | |
| argenx SE 1AE.F | $342.8 374.73 USD |
+4.29
|
$21.38B 23.37B USD | $2 2.19 USD | $342.8 374.73 USD | $342.8 374.73 USD | $21.38B 23.37B USD | 0 | -$5.26 -5.7 USD | |
| BioNTech SE B1NT34.SA | $29.64 6.01 USD |
0
|
$114.29B 23.16B USD | $0 0 USD | $29.64 6.01 USD | $29.64 6.01 USD | $114.29B 23.16B USD | 185.25 | $0.16 0.03 USD | |
| argenx SE A1RG34.SA | $73.36 14.87 USD |
0
|
$113.76B 23.06B USD | $0 0 USD | $73.36 14.87 USD | $73.36 14.87 USD | $113.76B 23.06B USD | 0 | -$29.14 -5.9 USD | |
| BioNTech SE BNTX.VI | $85.7 93.68 USD |
+0.88
|
$20.73B 22.66B USD | $100 109.31 USD | $84.4 92.26 USD | $85.7 93.68 USD | $20.73B 22.66B USD | 182.34 | $0.47 0.51 USD | |
| BioNTech SE 22UA.F | $84.65 92.53 USD |
+0.53
|
$20.66B 22.58B USD | $741 810.01 USD | $84.1 91.93 USD | $85.95 93.95 USD | $20.66B 22.58B USD | 180.10 | $0.47 0.51 USD | |
| argenx SE ARGX.VI | $333.9 365 USD |
0
|
$20.5B 22.41B USD | $0 0 USD | $333.9 365 USD | $333.9 365 USD | $20.5B 22.41B USD | 0 | -$5.28 -5.7 USD | |
| argenx SE ARGNF | $373.5 — |
0
|
$22.2B — | $1K — | $373.5 — | $373.5 — | $22.2B — | 0 | -$5.68 — | |
| Genmab A/S GNMSF | $301.97 — |
+3.58
|
$20.02B — | $856 — | $291.08 — | $301.97 — | $20.02B — | 25.14 | $12.01 — | |
| Alnylam Pharmaceuticals, Inc. A1LN34.SA | $37.68 7.64 USD |
-3.19
|
$95.32B 19.32B USD | $1 0.2 USD | $37.68 7.64 USD | $37.68 7.64 USD | $95.32B 19.32B USD | 0 | -$0.68 -0.1 USD | |
| Genmab A/S GMAB.VI | $273.1 298.54 USD |
-1.87
|
$17.64B 19.28B USD | $0 0 USD | $273.1 298.54 USD | $278 303.89 USD | $17.64B 19.28B USD | 24.53 | $11.13 12.17 USD | |
| BeiGene, Ltd. B1GN34.SA | $34.94 7.08 USD |
+3.62
|
$94.83B 19.22B USD | $4 0.81 USD | $34.94 7.08 USD | $34.94 7.08 USD | $94.83B 19.22B USD | 0 | -$2.98 -0.6 USD | |
| BeiGene, Ltd. 49BA.F | $155 169.44 USD |
+4.73
|
$17.58B 19.22B USD | $20 21.86 USD | $153 167.25 USD | $155 169.44 USD | $17.58B 19.22B USD | 0 | -$6.97 -7.6 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.F | $134.5 147.03 USD |
-0.88
|
$17.09B 18.68B USD | $7 7.65 USD | $134.5 147.03 USD | $134.5 147.03 USD | $17.09B 18.68B USD | 0 | -$2.44 -2.6 USD | |
| BeiGene, Ltd. 49B.F | $11.8 12.9 USD |
+2.61
|
$16.93B 18.5B USD | $340 371.67 USD | $11.8 12.9 USD | $11.8 12.9 USD | $16.93B 18.5B USD | 0 | -$0.54 -0.5 USD | |
| BioMarin Pharmaceutical Inc. BMRN.MX | $1,557.87 92.24 USD |
0
|
$295.81B 17.52B USD | $0 0 USD | $1,557.87 92.24 USD | $1,557.87 92.24 USD | $295.81B 17.52B USD | 86.93 | $17.92 1.06 USD | |
| Royalty Pharma plc RPD.MU | $26 28.42 USD |
-0.73
|
$15.47B 16.91B USD | $100 109.31 USD | $26 28.42 USD | $26 28.42 USD | $15.47B 16.91B USD | 15.85 | $1.64 1.79 USD | |
| Royalty Pharma plc RPD.F | $25.45 27.82 USD |
-1.09
|
$15.42B 16.85B USD | $50 54.66 USD | $25.45 27.82 USD | $25.51 27.89 USD | $15.42B 16.85B USD | 15.42 | $1.65 1.8 USD | |
| BioMarin Pharmaceutical Inc. BM8.DE | $81.02 88.57 USD |
0
|
$15.26B 16.68B USD | $23 25.14 USD | $80.76 88.28 USD | $81.08 88.63 USD | $15.26B 16.68B USD | 115.74 | $0.7 0.77 USD | |
| BioMarin Pharmaceutical Inc. BM8.F | $74.12 81.02 USD |
+1.06
|
$14.27B 15.6B USD | $200 218.63 USD | $73.64 80.5 USD | $74.12 81.02 USD | $14.27B 15.6B USD | 75.63 | $0.98 1.07 USD | |
| BioMarin Pharmaceutical Inc. B1MR34.SA | $197.8 40.09 USD |
-4.75
|
$75.12B 15.22B USD | $25 5.07 USD | $197.8 40.09 USD | $204 41.35 USD | $75.12B 15.22B USD | 72.72 | $2.72 0.55 USD | |
| BioMarin Pharmaceutical Inc. BMRN.VI | $71.22 77.85 USD |
-3.23
|
$13.66B 14.93B USD | $0 0 USD | $71.22 77.85 USD | $74.06 80.96 USD | $13.66B 14.93B USD | 72.67 | $0.98 1.07 USD | |
| Bio-Techne Corporation T1CH34.SA | $14.28 2.89 USD |
0
|
$67.51B 13.68B USD | $0 0 USD | $14.28 2.89 USD | $14.28 2.89 USD | $67.51B 13.68B USD | 68.00 | $0.21 0.04 USD | |
| Incyte Corporation I1NC34.SA | $136.64 27.69 USD |
0
|
$65.82B 13.34B USD | $0 0 USD | $136.64 27.69 USD | $136.64 27.69 USD | $65.82B 13.34B USD | 16.13 | $8.47 1.72 USD | |
| Incyte Corporation INCY.MX | $986 58.38 USD |
0
|
$221.71B 13.13B USD | $0 0 USD | $986 58.38 USD | $986 58.38 USD | $221.71B 13.13B USD | 17.73 | $55.61 3.29 USD | |
| Bio-Techne Corporation TE1.F | $76 83.08 USD |
-3.18
|
$11.98B 13.09B USD | $2 2.19 USD | $76 83.08 USD | $76 83.08 USD | $11.98B 13.09B USD | 66.08 | $1.15 1.26 USD | |
| Sarepta Therapeutics, Inc. S1RP34.SA | $34.11 6.91 USD |
0
|
$64.48B 13.07B USD | $0 0 USD | $34.11 6.91 USD | $34.11 6.91 USD | $64.48B 13.07B USD | 310.09 | $0.11 0.02 USD | |
| Incyte Corporation ICY.F | $52 56.84 USD |
-1.14
|
$11.73B 12.82B USD | $140 153.04 USD | $52 56.84 USD | $52.42 57.3 USD | $11.73B 12.82B USD | 17.04 | $3.05 3.33 USD | |
| Karuna Therapeutics KRTX | $329.83 — |
0
|
$12.6B — | $0 — | $0 — | $0 — | $12.6B — | 0 | $0 — | |
| Sarepta Therapeutics, Inc. AB3A.F | $121.2 132.49 USD |
-0.7
|
$11.5B 12.57B USD | $38 41.54 USD | $121.2 132.49 USD | $121.2 132.49 USD | $11.5B 12.57B USD | 303.00 | $0.4 0.44 USD | |
| Karuna Therapeutics, Inc. KRTX.MX | $3,226.17 191.03 USD |
0
|
$209.06B 12.38B USD | $0 0 USD | $0 0 USD | $0 0 USD | $209.06B 12.38B USD | 0 | $0 0 USD | |
| United Therapeutics Corporation UTH.F | $249 272.19 USD |
+0.65
|
$11.26B 12.31B USD | $15 16.4 USD | $249 272.19 USD | $249 272.19 USD | $11.26B 12.31B USD | 12.75 | $19.52 21.34 USD | |
| Bio-Techne Corporation TECH.MX | $1,310.32 77.59 USD |
-2.54
|
$206.49B 12.23B USD | $0 0 USD | $0 0 USD | $0 0 USD | $206.49B 12.23B USD | 51.58 | $25.4 1.5 USD | |
| Roivant Sciences Ltd. 87S.F | $10.15 11.09 USD |
+0.9
|
$8.65B 9.45B USD | $1K 1.09K USD | $10.1 11.04 USD | $10.15 11.09 USD | $8.65B 9.45B USD | 2.08 | $4.87 5.32 USD | |
| ImmunoGen, Inc. IMU.F | $28.74 31.42 USD |
0
|
$8.08B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $8.08B 8.83B USD | 0 | $0 0 USD | |
| ImmunoGen, Inc. IMGN.MX | $268.5 15.9 USD |
0
|
$149.06B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $149.06B 8.83B USD | 0 | $0 0 USD | |
| ImmunoGen IMGN | $31.23 — |
0
|
$8.72B — | $0 — | $0 — | $0 — | $8.72B — | 0 | $0 — | |
| Legend Biotech Corporation 9LB.F | $42.2 46.13 USD |
+0.96
|
$7.79B 8.51B USD | $20 21.86 USD | $41.6 45.47 USD | $42.2 46.13 USD | $7.79B 8.51B USD | 0 | -$2.39 -2.6 USD | |
| Vaxcyte, Inc. 5VA.F | $65.5 71.6 USD |
+5.65
|
$7.61B 8.32B USD | $4 4.37 USD | $65.5 71.6 USD | $65.5 71.6 USD | $7.61B 8.32B USD | 0 | -$3.97 -4.3 USD | |
| Vaxcyte, Inc. 5VA.MU | $65.5 71.6 USD |
+5.65
|
$7.61B 8.32B USD | $10 10.93 USD | $65.5 71.6 USD | $65.5 71.6 USD | $7.61B 8.32B USD | 0 | -$3.97 -4.3 USD | |
| Innovent Biologics, Inc. 6IB.F | $4.64 5.07 USD |
0
|
$7.57B 8.28B USD | $520 568.43 USD | $4.62 5.05 USD | $4.64 5.07 USD | $7.57B 8.28B USD | 0 | -$0.08 -0.08 USD | |
| Innovent Biologics IVBXF | $5.1 — |
+0.39
|
$8.27B — | $15.65K — | $5.08 — | $5.13 — | $8.27B — | 0 | -$0.09 — | |
| WuXi Biologics (Cayman) Inc. 1FW2.F | $1.73 1.89 USD |
+2.38
|
$7.31B 7.99B USD | $800 874.51 USD | $1.71 1.87 USD | $1.76 1.93 USD | $7.31B 7.99B USD | 17.29 | $0.1 0.11 USD | |
| WuXi Biologics (Cayman) Inc. 1FW1.F | $3.3 3.61 USD |
+1.23
|
$7.22B 7.9B USD | $1.05K 1.14K USD | $3.3 3.61 USD | $3.3 3.61 USD | $7.22B 7.9B USD | 16.50 | $0.2 0.22 USD | |
| Ionis Pharmaceuticals, Inc. IONS.MX | $900 53.29 USD |
0
|
$131.37B 7.78B USD | $0 0 USD | $900 53.29 USD | $900 53.29 USD | $131.37B 7.78B USD | 0 | -$42.65 -2.5 USD | |
| Viking Therapeutics, Inc. 1VT.F | $63.14 69.02 USD |
-11.37
|
$7.05B 7.7B USD | $2.19K 2.4K USD | $63.14 69.02 USD | $72.02 78.73 USD | $7.05B 7.7B USD | 0 | -$0.85 -0.9 USD | |
| Sino Biopharmaceutical Limited SMZ1.F | $0.3599 0.39 USD |
+1.58
|
$6.91B 7.56B USD | $1.4K 1.53K USD | $0.3599 0.39 USD | $0.3599 0.39 USD | $6.91B 7.56B USD | 35.99 | $0.01 0.01 USD | |
| Exelixis, Inc. EX9.DE | $21.09 23.05 USD |
0
|
$6.79B 7.42B USD | $92 100.57 USD | $21.09 23.05 USD | $21.09 23.05 USD | $6.79B 7.42B USD | 23.17 | $0.91 0.99 USD | |
| Sino Biopharmaceutical SBHMY | $7.2 — |
0
|
$7.36B — | $37 — | $7.2 — | $7.2 — | $7.36B — | 25.71 | $0.28 — | |
| Sino Biopharmaceutical Limited SBMFF | $0.32 — |
0
|
$7.36B — | $500 — | $0.32 — | $0.32 — | $7.36B — | 31.49 | $0.01 — | |
| Ascendis Pharma A/S A1SN34.SA | $48.42 9.81 USD |
0
|
$36.03B 7.3B USD | $0 0 USD | $48.42 9.81 USD | $48.42 9.81 USD | $36.03B 7.3B USD | 0 | -$49.21 -9.9 USD | |
| Ascendis Pharma A/S A71.F | $114 124.62 USD |
-0.87
|
$6.45B 7.06B USD | $1K 1.09K USD | $114 124.62 USD | $114 124.62 USD | $6.45B 7.06B USD | 0 | -$8.87 -9.6 USD | |
| Jazz Pharmaceuticals plc J7Z.F | $101.05 110.46 USD |
+0.1
|
$6.4B 7B USD | $888 970.7 USD | $100.15 109.48 USD | $101.05 110.46 USD | $6.4B 7B USD | 22.65 | $4.46 4.88 USD | |
| Revolution Medicines, Inc. 42Z.F | $36 39.35 USD |
+4.65
|
$6.29B 6.87B USD | $30 32.79 USD | $36 39.35 USD | $36 39.35 USD | $6.29B 6.87B USD | 0 | -$3.55 -3.8 USD | |
| Blueprint Medicines Corporation 2L9.F | $97.7 106.8 USD |
-0.55
|
$6.15B 6.72B USD | $137 149.76 USD | $96.78 105.79 USD | $101.1 110.52 USD | $6.15B 6.72B USD | 0 | -$4.46 -4.8 USD | |
|
Không có cổ phiếu ưa thích
Bạn chưa có cổ phiếu ưa thích nào, hãy thêm nó vào mục ưa thích để thấy nó tại đây |
||||||||||